Family Office

AMR Action Fund

Ennetburgen, Switzerland

Type

Family Office

Check size

n/a

Verticals

biotech, antimicrobial resistance, antibiotics

Investment thesis

AMR Action Fund is a global initiative launched in 2020 to address the growing threat of antimicrobial resistance by investing in the development of new antibiotics and related treatments. The fund is backed by leading pharmaceutical companies, foundations, and development banks, with a goal to bring two to four new antibiotics to market by 2030. Headquartered in Switzerland, AMR Action Fund collaborates with biotech firms and research organizations worldwide, providing both capital and expertise to advance promising antimicrobial candidates. The fund is recognized for its role in bridging the critical funding gap in antibiotic development and for advocating for policy reforms to support sustainable innovation in the sector.

Recent investments

→BioVersys
→BiomX
→Venatorx Pharmaceuticals

+ 3 more deals. Score your deck to see the full investment history.

Partners

3 partners on file at this firm, with the firm's email pattern for cold outreach.

Partner names + email patterns are part of the deck-upload bundle. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 40,000+ others.

Score my deck → unlock contacts

Investment focus

Business models

biotech_therapeutics

Customer segments

Hospitals, Healthcare providers, Patients, Government health agencies

Geography

US, Europe, Global

Links

Want to know if AMR Action Fund is the right fit for your deck?

Drop your pitch deck. Claude scores it on the 8 dimensions VCs evaluate and tells you which of the 40,000+ firms in our database are the best matches.

Score your deck (free, 30 seconds) →